FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Anthony D'Amico

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Prostate

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Arti Parekh; Oliver Sartor; Karen Stein; Charles L Bennett; Ming-Hui Chen; Toni K Choueiri; Anthony V D'Amico; Powell L Graham; Karen E Hoffman; Jim C Hu; Michael W Kattan; Paul L Nguyen
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
Jona A Hattangadi; Ming-Hui Chen; Anthony V D'Amico
Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Neil E Martin; Paul L Nguyen; Clair Beard; Ming-Hui Chen; Philip W Kantoff; Marian Loffredo; Anthony V D'Amico
Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Anthony D'Amico (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Arti Parekh; Oliver Sartor; Karen Stein; Charles L Bennett; Ming-Hui Chen; Toni K Choueiri; Anthony V D'Amico; Powell L Graham; Karen E Hoffman; Jim C Hu; Michael W Kattan; Paul L Nguyen
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
Urology 2013;81(1):130-4.
2012: Jona A Hattangadi; Ming-Hui Chen; Anthony V D'Amico
Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
BJU international 2012;110(11):1636-41.
2012: Neil E Martin; Paul L Nguyen; Clair Beard; Ming-Hui Chen; Philip W Kantoff; Marian Loffredo; Anthony V D'Amico
Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.
BJU international 2012;110(9):1252-6.
2012: Paul L Nguyen; W Warren Suh; Clare M Tempany; Yuanye Zhang; Clair Beard; Ming-Hui Chen; Robert A Cormack; Mark D Hurwitz; Anthony V D'Amico
Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy.
The Journal of urology 2012;188(4):1151-6.
2012: Kenneth Westover; Ming-Hui Chen; Daniel Dosoretz; Michael J Katin; Judd Moul; Thomas Polascik; Cary Robertson; Sharon Salenius; Anthony V D'Amico
Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
BJU international 2012;110(8):1116-21.
2012: Ayal A Aizer; Clair Beard; Anthony V D'Amico; Michelle S Hirsch; Irving D Kaplan; M Dror Michaelson; Paul Nguyen; Andrzej Niemierko; Aria F Olumi; Jonathan J Paly; Sandhya K Rao; Chin-Lee Wu; Anthony L Zietman; Jason A Efstathiou
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3071-6.
2012: Wesley W Choi; Anthony V D'Amico; Xiangmei Gu; Stuart R Lipsitz; Stephen B Williams; Jim C Hu
The effect of minimally invasive and open radical prostatectomy surgeon volume.
Urologic oncology 2012;30(5):569-76.
2012: Paul L Nguyen; Oliver Sartor; Karen Stein; Karen E Hoffman; Jim C Hu; Michael W Kattan; Charles L Bennett; Ming-Hui Chen; Ronald C Chen; Anthony V D'Amico
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
BJU international 2012;110(2):201-5.
2012: Yolanda D Tseng; Peter F Orio; Andrew A Renshaw; Clair J Beard; Ming-Hui Chen; Toni K Choueiri; Anthony V D'Amico; Jim C Hu; Philip W Kantoff; Marian Loffredo; Neil E Martin; Paul L Nguyen
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality.
The Journal of urology 2012;187(6):2068-73.
2012: Sook Kien Ng; Piotr Zygmanski; Anthony V D'Amico; Yulia Lyatskaya; Robert A Cormack
Localization of a portion of an endorectal balloon for prostate image-guided radiation therapy using cone-beam tomosynthesis: a feasibility study.
International journal of radiation oncology, biology, physics 2012;83(2):e257-64.
2012: Daniel A Wattson; Michelle H Braccioforte; Ming-Hui Chen; Daniel E Dosoretz; Brian J Moran; Judd W Moul; Thomas J Polascik; Cary N Robertson; Sharon A Salenius; Anthony V D'Amico
The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection.
International journal of radiation oncology, biology, physics 2012;82(5):e773-9.
2012: Paul Nguyen; Sharon A Salenius; Karen E Hoffman; Jim C Hu; Philip W Kantoff; Neil E Martin; Brian J Moran; Clair Beard; Joshua A Beckman; Michelle H Braccioforte; Ming-Hui Chen; Toni K Choueiri; Anthony V D'Amico; Daniel E Dosoretz; Ronald Ennis
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction.
International journal of radiation oncology, biology, physics 2012;82(4):1411-6.
2012: Jonathan E Rosenberg; Michelle H Braccioforte; Ming-Hui Chen; Brian J Moran; Paul L Nguyen; Anthony V D'Amico
Hormonal therapy or external-beam radiation with brachytherapy and the risk of death from prostate cancer in men with intermediate risk prostate cancer.
Clinical genitourinary cancer 2012;10(1):21-5.
2012: Josephine Kang; Michael J Katin; Brian J Moran; Sharon A Salenius; Yuanye Zhang; Michelle H Braccioforte; Ming-Hui Chen; Daniel E Dosoretz; Anthony V D'Amico
Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer.
International journal of radiation oncology, biology, physics 2012;82(3):e463-7.
2012: Jessica J Park; Marian Loffredo; Ming-Hui Chen; Anthony V D'Amico
Prostate-specific antigen velocity before and after elimination of factors that can confound the prostate-specific antigen level.
International journal of radiation oncology, biology, physics 2012;82(3):1217-21.
2012: Anthony V D'Amico; Mario de Castro; Ming-Hui Chen; Philip W Kantoff; David S Lamb; Marian Loffredo; Allison Steigler; James W Denham
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
The lancet oncology 2012;13(2):189-95.
2011: Timur Mitin; Brian J Moran; Sharon A Salenius; Yuanye Zhang; Michelle H Braccioforte; Ming-Hui Chen; Daniel E Dosoretz; Michael J Katin; Anthony V D'Amico
Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy.
The Journal of urology 2011;186(6):2233-7.
2011: Karen M Winkfield; Ming-Hui Chen; Daniel E Dosoretz; Michael J Katin; Rudi Ross; Sharon A Salenius; Anthony V D'Amico
Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
International journal of radiation oncology, biology, physics 2011;81(4):e345-50.
2011: Anthony V D'Amico; Daniel Dosoretz; Michael J Katin; Rudi Ross; Sharon Salenius; Ming-Hui Chen; Samuel Z Goldhaber
Coronary artery revascularization and the risk of death in men with prostate cancer.
The Journal of urology 2011;186(3):898-902.
2011: Shane E Cotter; Mitchell S. Anscher; Ming Hui Chen; Bridget F Koontz; W Robert Lee; Judd W Moul; Thomas J Polascik; Cary N Robertson; Philip J Walther; Anthony V D'Amico
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
Cancer 2011;117(17):3925-32.
2011: Jona A Hattangadi; Brian J Moran; Michelle H Braccioforte; Ming-Hui Chen; Anthony V D'Amico
Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice.
Brachytherapy 2011;10(5):369-75.
2011: Nils D Arvold; Lionel L Bañez; Michelle H Braccioforte; Ming-Hui Chen; Daniel E Dosoretz; Michael J Katin; Brian J Moran; Judd W Moul; Anthony V D'Amico
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.
The Journal of urology 2011;186(1):91-6.
2011: Paul Nguyen; Ming H Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Neil E Martin; Clair J Beard; Daniel E Dosoretz; Brian J Moran; Michael J Katin; Michelle H Braccioforte; Rudi Ross; Sharon A Salenius; Philip W Kantoff; Anthony V D'Amico
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size.
International journal of radiation oncology, biology, physics 2011;79(5):1318-22.
2011: E David Crawford; Robert Grubb; Amanda Black; Gerald L Andriole; Ming-Hui Chen; Grant Izmirlian; Christine D Berg; Anthony V D'Amico
Comorbidity and mortality results from a randomized prostate cancer screening trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(4):355-61.
2011: Jim C Hu; Sandip M Prasad; Xiangmei Gu; Stephen B Williams; Stuart R Lipsitz; Paul L Nguyen; Toni K Choueiri; Wesley W Choi; Anthony V D'Amico
Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.
Urology 2011;77(2):402-6.
2011: Paul Nguyen; Ming H Chen; Samuel Z Goldhaber; Neil E Martin; Clair Beard; Daniel E Dosoretz; Michael J Katin; Rudi Ross; Sharon A Salenius; Anthony V D'Amico
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation.
Cancer 2011;117(2):406-13.
2011: Karen E Hoffman; Paul L Nguyen; Ming-Hui Chen; Ronald C Chen; Toni K Choueiri; Jim C Hu; Deborah A Kuban; Anthony V D'Amico
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.
The Journal of urology 2011;185(1):116-20.
2010: Anthony V D'Amico; Ming-Hui Chen; Leon Sun; W Robert Lee; Vladimir Mouraviev; Cary N Robertson; Philip J Walther; Thomas J Polascik; David M Albala; Judd W Moul
Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death.
BJU international 2010;106(11):1618-22.
2010: Stephen B Williams; Ming-Hui Chen; Anthony V D'Amico; Aaron C Weinberg; Ravi Kacker; Michelle S Hirsch; Jerome P Richie; Jim C Hu
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s).
Urology 2010;76(5):1097-101.
2010: Julia H Hayes; Ming-Hui Chen; Brian J Moran; Michelle H Braccioforte; Daniel E Dosoretz; Sharon Salenius; Michael J Katin; Rudi Ross; Toni K Choueiri; Anthony V D'Amico
Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke.
BJU international 2010;106(7):979-85.
2010: Anthony V D'Amico; Michelle H Braccioforte; Brian J Moran; Ming-Hui Chen
Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.
International journal of radiation oncology, biology, physics 2010;77(5):1329-37.
2010: Paul L Nguyen; Anthony V D'Amico
Deciding which patients to treat with salvage radiotherapy after prostatectomy.
Oncology (Williston Park, N.Y.) 2010;24(8):705, 711.
2010: Karen E Hoffman; Ming-Hui Chen; Brian J Moran; Michelle H Braccioforte; Daniel Dosoretz; Sharon Salenius; Michael J Katin; Rudi Ross; Anthony V D'Amico
Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
Cancer 2010;116(11):2590-5.
2010: Karen E Hoffman; Paul L Nguyen; Andrea K Ng; Anthony V D'Amico
Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
The Journal of urology 2010;183(5):1798-802.
2010: Akash Nanda; Ming-Hui Chen; Brian J Moran; Michelle H Braccioforte; Daniel Dosoretz; Sharon Salenius; Michael Katin; Rudi Ross; Anthony V D'Amico
Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.
International journal of radiation oncology, biology, physics 2010;77(1):147-52.
2010: Arthur K Cheung; Ming-Hui Chen; Brian J Moran; Michelle H Braccioforte; Daniel E Dosoretz; Sharon Salenius; Michael Katin; Rudi Ross; Anthony V D'Amico
The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement.
Brachytherapy 2010;9(2):145-50.
2010: Akash Nanda; Ming-Hui Chen; Brian J Moran; Michelle H Braccioforte; Daniel Dosoretz; Sharon Salenius; Michael Katin; Rudi Ross; Anthony V D'Amico
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.
International journal of radiation oncology, biology, physics 2010;76(5):1439-44.
2010: Paul Nguyen; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Philip W Kantoff; Anthony V D'Amico
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations.
International journal of radiation oncology, biology, physics 2010;76(2):337-41.
2010: Anthony V D'Amico; Michelle H Braccioforte; Brian J Moran; Ming-Hui Chen
Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease.
Alzheimer disease and associated disorders 2010;24(1):85-9.
2009: Jennifer Y Wo; Ming-Hui Chen; Paul Nguyen; Andrew A Renshaw; Marian Loffredo; Philip W Kantoff; Anthony V D'Amico
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6000-5.
2009: Jim C Hu; Xiangmei Gu; Stuart R Lipsitz; Michael J Barry; Anthony V D'Amico; Aaron C Weinberg; Nancy L Keating
Comparative effectiveness of minimally invasive vs open radical prostatectomy.
JAMA : the journal of the American Medical Association 2009;302(14):1557-64.
2009: Paul Nguyen; Ronald Chen; Jack A Clark; Robert Cormack; Marian Loffredo; Elizabeth McMahon; Angela U Nguyen; W Warren Suh; Clare M C Tempany; Anthony V D'Amico
Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study.
Brachytherapy 2009;8(4):345-52.
2009: Anthony V D'Amico; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Philip W Kantoff
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
International journal of radiation oncology, biology, physics 2009;75(1):10-5.
2009: Ronald Chen; Natalia Sadetsky; Ming-Hui Chen; Peter R Carroll; Anthony V D'Amico
Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
International journal of radiation oncology, biology, physics 2009;75(1):36-9.
2009: Akash Nanda; Ming-Hui Chen; Michelle H Braccioforte; Brian J Moran; Anthony V D'Amico
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
JAMA : the journal of the American Medical Association 2009;302(8):866-73.
2009: Anthony V D'Amico; Brian J Moran; Michelle H Braccioforte; Daniel Dosoretz; Sharon Salenius; Michael Katin; Rudi Ross; Ming-Hui Chen
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3923-8.
2009: Akash Nanda; Ming-Hui Chen; Andrew A Renshaw; Anthony V D'Amico
Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
International journal of radiation oncology, biology, physics 2009;74(5):1419-23.
2009: Paul Nguyen; Ming-Hui Chen; Karen E Hoffman; Matthew Katz; Anthony V D'Amico
Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.
International journal of radiation oncology, biology, physics 2009;74(1):104-9.
2009: Paul Nguyen; Ming-Hui Chen; William J Catalona; Judd W Moul; Leon Sun; Anthony V D'Amico
Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors.
International journal of radiation oncology, biology, physics 2009;73(3):659-64.
2008: Paul Nguyen; Ming-Hui Chen; William J Catalona; Brian M Alexander; Kimberly A Roehl; Stacy Loeb; Anthony V D'Amico
Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for management.
Cancer 2008;113(11):3146-52.
2008: Akash Nanda; Anthony V D'Amico
Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
BJU international 2008;102(10):1366-8.
2008: Benjamin D Sommers; Clair Beard; Anthony V D'Amico; Irving Kaplan; Jerome P Richie; Richard J Zeckhauser
Predictors of patient preferences and treatment choices for localized prostate cancer.
Cancer 2008;113(8):2058-67.
2008: Karen E Hoffman; Ming-Hui Chen; Rinaa S Punglia; Clair Beard; Anthony V D'Amico
Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3937-42.
2008: Anthony V D'Amico; Ming-Hui Chen; Andrew A Renshaw; Brittany Loffredo; Philip W Kantoff
Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2979-83.
2008: Philip M Arlen; Fernando Bianco; William L Dahut; Anthony V D'Amico; William D Figg; Stephen J Freedland; James L Gulley; Philip W Kantoff; Michael W Kattan; Andrew Lee; Meredith M Regan; Oliver Sartor
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
The Journal of urology 2008;179(6):2181-5; discussion 2185-6.
2008: O Kenneth Macdonald; Anthony V D'Amico; Natalia Sadetsky; Dennis C Shrieve; Peter R Carroll
Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database.
Urologic oncology 2008;26(3):271-5.
2008: Manish Vira; THOMAS GUZZO; Daniel F Heitjan; John E Tomaszewski; Anthony V D'Amico; Alan J Wein; S Bruce Malkowicz
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
BJU international 2008;101(10):1232-6.
2008: Anthony V D'Amico; Susan Halabi; Robin Vollmer; Marian Loffredo; Elizabeth McMahon; Ben Sanford; Laura Archer; Nicholas J Vogelzang; Eric J Small; Philip W Kantoff
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
Urology 2008;71(5):933-7.
2008: Anthony V D'Amico; Susan Halabi; Clare M C Tempany; David S Titelbaum; George K Philips; Marian Loffredo; Elizabeth McMahon; Ben Sanford; Nicholas J Vogelzang; Eric J Small
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
International journal of radiation oncology, biology, physics 2008;71(1):9-15.
2008: Paul Nguyen; Anthony V D'Amico
Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):2055-6; author reply 2056-7.
2008: Michele Albert; Jun S Song; Delray Schultz; Robert Cormack; Clare M C Tempany; Steve Haker; Phillip M Devlin; Clair Beard; Mark Hurwitz; Wonsuk W Suh; Ferenc Jolesz; Anthony V D'Amico
Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.
Urologic oncology 2008;26(2):147-52.
2008: Shomik Sengupta; Christopher L Amling; Anthony V D'Amico; Michael L Blute
Prostate specific antigen kinetics in the management of prostate cancer.
The Journal of urology 2008;179(3):821-6.
2008: Anthony V D'Amico
Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):823-4.
2008: Anthony V D'Amico; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Philip W Kantoff
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2008;299(3):289-95.
2008: Christine S Chung; Ming-Hui Chen; Jennifer Cullen; David McLeod; Peter Carroll; Anthony V D'Amico
Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
Urology 2008;71(1):136-40.
2007: Anthony V D'Amico; Philip W Kantoff; Ming-Hui Chen
Aspirin and hormone therapy for prostate cancer.
The New England journal of medicine 2007;357(26):2737-8.
2007: Benjamin D Sommers; Clair Beard; Anthony V D'Amico; Douglas Dahl; Irving Kaplan; Jerome P Richie; Richard J Zeckhauser
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
Cancer 2007;110(10):2210-7.
2007: Rinaa S Punglia; Jennifer Cullen; David G McLeod; Yongmei Chen; Anthony V D'Amico
Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
Cancer 2007;110(9):1973-8.
2007: Henry K Tsai; Anthony V D'Amico; Natalia Sadetsky; Ming-Hui Chen; Peter R Carroll
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Journal of the National Cancer Institute 2007;99(20):1516-24.
2007: Anthony V D'Amico; Andrew A Renshaw; Brittany Loffredo; Ming-Hui Chen
Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
Cancer 2007;110(8):1723-8.
2007: Abhijit A Patel; Ming-Hui Chen; Andrew A Renshaw; Anthony V D'Amico
PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
JAMA : the journal of the American Medical Association 2007;298(13):1533-8.
2007: Paul Nguyen; Ming-Hui Chen; Anthony V D'Amico; Clare M C Tempany; Graeme S Steele; Michele Albert; Robert Cormack; David L. Carr-Locke; Ronald Bleday; W Warren Suh
Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study.
Cancer 2007;110(7):1485-92.
2007: Paul Nguyen; Anthony V D'Amico; Andrew K Lee; W Warren Suh
Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.
Cancer 2007;110(7):1417-28.
2007: Philip W Kantoff; Tomasz M Beer; Anthony V D'Amico; Robert S Dipaola; Mario A Eisenberger; Maha Hussain; W Kevin Kelly; Paul Mathew; Michael J Morris; Charles J Ryan; Howard M Sandler; Ian M Thompson; Peter R Carroll
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
The Journal of urology 2007;178(3 Pt 2):S5-8; quiz S4.
2007: Brian M Alexander; Ming-Hui Chen; Peter Carroll; Anthony V D'Amico
Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response.
Urology 2007;70(2):320-3.
2007: Paul Nguyen; Ming-Hui Chen; Andrew A Renshaw; Brenda Sussman; Anthony V D'Amico
Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality.
Urology 2007;70(2):288-93.
2007: James Mohler; Richard J Babaian; Robert R Bahnson; Barry Boston; Anthony V D'Amico; James A Eastham; Ralph J Hauke; Robert P Huben; Philip W Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Chris Logothetis; Gary MacVicar; Alan Pollack; Julio Pow-Sang; Mack Roach; Howard Sandler; Dennis C Shrieve; Sandhya Srinivas; Przemyslaw Twardowski; Donald A Urban; Patrick C Walsh
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Andrew K Lee; Anthony V D'Amico
Using prostate-specific antigen doubling time in clinical practice.
BJU international 2007;100(2):243-4.
2007: O Kenneth Macdonald; Anthony V D'Amico; Natalia Sadetsky; Dennis C Shrieve; Peter R Carroll
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
Urology 2007;70(1):106-10.
2007: Anthony V D'Amico; Ming-Hui Chen; William J Catalona; Leon Sun; Kimberly A Roehl; Judd W Moul
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
Cancer 2007;110(1):56-61.
2007: Anthony V D'Amico; James W Denham; Juanita Crook; Ming-Hui Chen; Samuel Z Goldhaber; David S Lamb; David Joseph; Keen-Hun Tai; Shawn Malone; Charles Ludgate; Allison Steigler; Philip W Kantoff
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2420-5.
2007: Anthony V D'Amico; James W Denham; Michel Bolla; Laurence Collette; David S Lamb; Keen-Hun Tai; Allison Steigler; Ming-Hui Chen
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
Cancer 2007;109(10):2004-10.
2007: Tracy A Balboni; Ming-Hui Chen; Jay R Harris; Abram Recht; Mary Ann Stevenson; Anthony V D'Amico
Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience.
International journal of radiation oncology, biology, physics 2007;68(1):183-6.
2007: Jason A Efstathiou; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Anthony V D'Amico
Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
Cancer 2007;109(8):1493-8.
2007: Anthony V D'Amico; David G McLeod; Peter R Carroll; Jennifer Cullen; Ming-Hui Chen
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
Cancer 2007;109(7):1290-5.
2007: Stephanie C Krejcarek; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Brenda Sussman; Anthony V D'Amico
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
Urology 2007;69(3):515-9.
2007: Anthony V D'Amico
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
BJU international 2007;99 Suppl 1():13-6; discussion 17-8.
2007: Anthony V D'Amico; Claus G Roehrborn
Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
The lancet oncology 2007;8(1):21-5.
2007: Anthony V D'Amico
Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):8-9.
2006: Anthony V D'Amico; Ming Hui-Chen; Andrew A Renshaw; Brenda Sussman; Kimberly A Roehl; William J Catalona
Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
The Journal of urology 2006;176(6 Pt 2):S11-5.
2006: Henry K Tsai; Ming-Hui Chen; David G McLeod; Peter R Carroll; Jerome P Richie; Anthony V D'Amico
Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
Cancer 2006;107(11):2597-603.
2006: Aileen B Chen; Anthony V D'Amico; Bridget A Neville; Craig C Earle
Patient and treatment factors associated with complications after prostate brachytherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5298-304.
2006: Anthony V D'Amico; Michael J Barry
Prostate cancer prevention and finasteride.
The Journal of urology 2006;176(5):2010-2; discussion 2012-3.
2006: Laurence E Court; Anthony V D'Amico; Dnyanesh Kadam; Robert Cormack
Motion and shape change when using an endorectal balloon during prostate radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;81(2):184-9.
2006: Joshua H Petit; Ming-Hui Chen; Marian Loffredo; Brenda Sussman; Andrew A Renshaw; Anthony V D'Amico
Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer.
Cancer 2006;107(9):2180-5.
2006: Clair Beard; Delray Schultz; Marian Loffredo; Kerri Cote; Andrew A Renshaw; Mark Hurwitz; Anthony V D'Amico
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(2):403-7.
2006: Anthony V D'Amico; Marian Loffredo; Andrew A Renshaw; Brittany Loffredo; Ming-Hui Chen
Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4190-5.
2006: Mark Hurwitz; Delray Schultz; Jerome P Richie; Alan J Wein; Richard Whittington; S Bruce Malkowicz; Anthony V D'Amico
Radical prostatectomy for high-grade prostate cancer.
Urology 2006;68(2):367-70.
2006: Jason A Efstathiou; Ming-Hui Chen; William J Catalona; David G McLeod; Peter R Carroll; Judd W Moul; Kimberly A Roehl; Anthony V D'Amico
Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.
Urology 2006;68(2):342-7.
2006: Neesha A Rodrigues; Ming-Hui Chen; William J Catalona; Kimberly A Roehl; Jerome P Richie; Anthony V D'Amico
Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer.
Cancer 2006;107(3):514-20.
2006: Anthony V D'Amico; Philip W Kantoff; Marian Loffredo; Andrew A Renshaw; Brittany Loffredo; Ming-Hui Chen
Predictors of mortality after prostate-specific antigen failure.
International journal of radiation oncology, biology, physics 2006;65(3):656-60.
2006: Anthony V D'Amico; Judith Manola; Elizabeth McMahon; Marian Loffredo; Lynn Lopes; Jane Ching; Michele Albert; Mark Hurwitz; Wonsuk Warren Suh; Todd A Vivenzio; Clair Beard
A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization.
Urology 2006;67(4):780-4.
2006: Rinaa S Punglia; Anthony V D'Amico; William J Catalona; Kimberly A Roehl; Karen M Kuntz
Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
Cancer 2006;106(7):1507-13.
2006: Shira L Galper; Ming-Hui Chen; William J Catalona; Kimberly A Roehl; Jerome P Richie; Anthony V D'Amico
Evidence to support a continued stage migration and decrease in prostate cancer specific mortality.
The Journal of urology 2006;175(3 Pt 1):907-12.
2006: THOMAS GUZZO; Manish Vira; Yanlin Wang; John Tomaszewski; Anthony V D'Amico; Alan J Wein; S Bruce Malkowicz
Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer.
The Journal of urology 2006;175(2):518-21; discussion 521-2.
2006: Flora Rozhansky; Ming-Hui Chen; Michael C Cox; William Dahut; William D Figg; Anthony V D'Amico
Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma.
Cancer 2006;106(1):63-7.
2005: Rinaa S Punglia; Karen M Kuntz; William J Catalona; Anthony V D'Amico
Operating characteristics of prostate-specific antigen and verification bias.
JAMA : the journal of the American Medical Association 2005;294(21):2698; author reply 2698-9.
2005: Agnieszka Szot Barnes; Steven Haker; Robert V Mulkern; Minna So; Anthony V D'Amico; Clare M C Tempany
Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer.
Urology 2005;66(6):1319.
2005: Andrew K Lee; Anthony V D'Amico
Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(32):8192-7.
2005: Cigall Kadoch; Anthony V D'Amico; Richard H Matthews
When prostate brachytherapy fails: a case report and discussion.
The oncologist 2005;10(10):799-805.
2005: Tomas Dvorak; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Jerome P Richie; Anthony V D'Amico
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer.
Urology 2005;66(5):1024-8.
2005: Clair Beard; Ming-Hui Chen; Kerri Cote; Marian Loffredo; Andrew Renshaw; Mark Hurwitz; Anthony V D'Amico
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer.
Urology 2005;66(5):1020-3.
2005: Manish Vira; John E Tomaszewski; Wei-Ting Hwang; Anthony V D'Amico; Richard Whittington; Keith VanArsdalen; Alan J Wein; S Bruce Malkowicz
Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients.
Urology 2005;66(5):1015-9.
2005: Ping Zhou; Ming-Hui Chen; David McLeod; Peter R Carroll; Judd W Moul; Anthony V D'Amico
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6992-8.
2005: Alexandra Stewart; Howard I Scher; Ming-Hui Chen; David G McLeod; Peter R Carroll; Judd W Moul; Anthony V D'Amico
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6556-60.
2005: Sarah J McAleer; Delray Schultz; Richard Whittington; S Bruce Malkowicz; Andrew Renshaw; Alan Wein; Jerome P Richie; Anthony V D'Amico
PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level.
Urologic oncology 2005;23(5):311-7.
2005: Anthony V D'Amico; Ming-Hui Chen; Michael C Cox; William Dahut; William D Figg
Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer.
Urology 2005;66(3):571-6.
2005: THOMAS GUZZO; Manish Vira; Wei-Ting Hwang; Anthony V D'Amico; John Tomaszewski; Richard Whittington; Alan J Wein; Keith VanArsdalen; S Bruce Malkowicz
Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy.
Urology 2005;66(2):361-5.
2005: Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4975-9.
2005: Anthony V D'Amico; Andrew A Renshaw; Brenda Sussman; Ming-Hui Chen
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.
JAMA : the journal of the American Medical Association 2005;294(4):440-7.
2005: Henry K Tsai; Judith Manola; Anthony Abner; James A Talcott; Anthony V D'Amico; Clair Beard
Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.
Urologic oncology 2005;23(4):230-7.
2005: Rosemonde Woel; Clair Beard; Ming-Hui Chen; Mark Hurwitz; Marian Loffredo; Elizabeth McMahon; Jane Ching; Lynn Lopes; Anthony V D'Amico
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization.
International journal of radiation oncology, biology, physics 2005;62(2):392-6.
2005: Paul Nguyen; Richard Whittington; Sophia Koo; Delray Schultz; Kerri Cote; Marian Loffredo; Elizabeth McMahon; Andrew A Renshaw; John E Tomaszewski; Anthony V D'Amico
The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma.
Cancer 2005;103(10):2053-9.
2005: Anthony V D'Amico; Judd W Moul; Peter R Carroll; Leon Sun; Deborah P Lubeck; Ming-Hui Chen
Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer.
The Journal of urology 2005;173(5):1572-6.
2005: Daniel M Landis; Delray Schultz; Robert Cormack; Clare M C Tempany; Clair Beard; Mark Hurwitz; Michael O'Leary; Michele Albert; Kristin Valentine; Anthony V D'Amico
Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy.
Urology 2005;65(4):750-4.
2005: Darlene D Lin; Delray Schultz; Andrew A Renshaw; Mark A Rubin; Jerome P Richie; Anthony V D'Amico
Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Urology 2005;65(3):528-32.
2005: Anthony V D'Amico
Screening for prostate carcinoma: prostate-specific antigen--friend or foe?
Cancer 2005;103(5):881-3.
2005: Jun S Song; Michele Albert; Anthony V D'Amico; Robert Cormack
A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results.
Medical physics 2005;32(2):437-47.
2004: Anthony V D'Amico; Judd W Moul; Peter R Carroll; Leon Sun; Deborah P Lubeck; Ming-Hui Chen
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy.
The Journal of urology 2004;172(5 Pt 2):S42-6; discussion S46-7.
2004: Anthony V D'Amico; Andrew A Renshaw; Kerri Cote; Mark Hurwitz; Clair Beard; Marian Loffredo; Ming-Hui Chen
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3726-32.
2004: Anthony V D'Amico; Judith Manola; Marian Loffredo; Andrew A Renshaw; Alyssa DellaCroce; Philip W Kantoff
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(7):821-7.
2004: Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.
The New England journal of medicine 2004;351(2):125-35.
2004: Paul Nguyen; Delray Schultz; Andrew A Renshaw; Robin T Vollmer; William R Welch; Kerri Cote; Anthony V D'Amico
The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate.
Urologic oncology 2004;22(4):295-9.
2004: Pearl Seo; Anthony V D'Amico; Jack A Clark; Irving Kaplan; Judith Manola; Sonya P Mitchell; James A Talcott
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?
Clinical prostate cancer 2004;3(1):38-42.
2004: Gary J Kelloff; Donald S Coffey; Bruce A Chabner; Adam Dicker; Kathryn Z Guyton; Perry D Nisen; Howard R Soule; Anthony V D'Amico
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3927-33.
2004: Gary J Kelloff; Robert C Bast; Donald S Coffey; Anthony V D'Amico; Robert S Kerbel; John W Park; Raymond W Ruddon; Gordon J S Rustin; Richard L Schilsky; Caroline C Sigman; George Vande Woude
Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3881-4.
2004: Paul Nguyen; Richard Whittington; Sophia Koo; Delray Schultz; Kerri Cote; Marian Loffredo; Clare M C Tempany; David S Titelbaum; Mitchell D Schnall; Andrew A Renshaw; John E Tomaszewski; Anthony V D'Amico
Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(2):400-5.
2004: Mona V Sanghani; Jane Ching; Delray Schultz; Robert Cormack; Marian Loffredo; Elizabeth McMahon; Clair Beard; Anthony V D'Amico
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.
Urologic oncology 2004;22(3):165-8.
2004: Anthony V D'Amico; Judd W Moul; Peter R Carroll; Kerri Cote; Leon Sun; Deborah P Lubeck; Andrew A Renshaw; Marian Loffredo; Ming-Hui Chen
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.
Journal of the National Cancer Institute 2004;96(7):509-15.
2004: Keith D Bloom; Jerome P Richie; Delray Schultz; Andrew Renshaw; Tara Saegaert; Anthony V D'Amico
Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
Urology 2004;63(2):333-6.
2004: Howard I Scher; Mario A Eisenberger; Anthony V D'Amico; Susan Halabi; Eric J Small; Michael J Morris; Michael W Kattan; Mack Roach; Philip W Kantoff; Kenneth Pienta; Michael A Carducci; David B Agus; Susan F Slovin; Glenn Heller; W Kevin Kelly; Paul H Lange; Daniel P Petrylak; William Berg; Celestia S Higano; George Wilding; Judd W Moul; Alan W Partin; Christopher Logothetis; Howard R Soule
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):537-56.
2004: Christoph F Dickhaus; Catherina Burghart; Clare M C Tempany; Anthony V D'Amico; Steven Haker; Ron Kikinis; Heinz Woern
Workflow modeling and analysis of computer guided prostate brachytherapy under MR imaging control.
Studies in health technology and informatics 2004;98():72-4.
2004: Clair Beard; M H Chen; Kerri Cote; Marian Loffredo; Andrew A Renshaw; Mark Hurwitz; Anthony V D'Amico
Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
International journal of radiation oncology, biology, physics 2004;58(1):19-24.
2003: Matthew Cooperberg; E J Small; Anthony V D'Amico; P R Carroll
The evolving role of androgen deprivation therapy in the management of prostate cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(4):219-38.
2003: Anthony V D'Amico; Clare M C Tempany; Delray Schultz; Robert Cormack; Mark Hurwitz; Clair Beard; Michele Albert; Hanne M Kooy; Ferenc A Jolesz; Jerome P Richie
Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.
Urology 2003;62(6):1063-7.
2003: Anthony V D'Amico; Kerri Cote; Marian Loffredo; Andrew A Renshaw; Delray Schultz
Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era.
The Journal of urology 2003;170(6 Pt 2):S42-6; discussion S46-7.
2003: James A Talcott; Judith Manola; Jack A Clark; Irving Kaplan; Clair Beard; Sonya P Mitchell; Ronald Chen; Michael P O'Leary; Philip W Kantoff; Anthony V D'Amico
Time course and predictors of symptoms after primary prostate cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3979-86.
2003: Anthony V D'Amico; Judd W Moul; Peter R Carroll; Leon Sun; Deborah P Lubeck; Ming-Hui Chen
Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Journal of the National Cancer Institute 2003;95(18):1376-83.
2003: Mona V Sanghani; Delray Schultz; Clare M C Tempany; David S Titelbaum; Andrew A Renshaw; Marian Loffredo; Kerri Cote; Beth McMahon; Anthony V D'Amico
Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer.
Urology 2003;62(3):487-91.
2003: Michele Albert; Clare M C Tempany; Delray Schultz; Ming-Hui Chen; Robert Cormack; Sanjaya Kumar; Mark Hurwitz; Clair Beard; Kemal Tuncali; Michael O'Leary; George P Topulos; Kristin Valentine; Lynn Lopes; Angela Kanan; Daniel Kacher; James Rosato; Hanne M Kooy; Ferenc A Jolesz; David L. Carr-Locke; Jerome P Richie; Anthony V D'Amico
Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy.
Cancer 2003;98(5):949-54.
2003: Andrew A Renshaw; Delray Schultz; Kerri Cote; Marian Loffredo; David E Ziemba; Anthony V D'Amico
Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists.
Archives of pathology & laboratory medicine 2003;127(8):1007-8.
2003: Rinaa S Punglia; Anthony V D'Amico; William J Catalona; Kimberly A Roehl; Karen M Kuntz
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
The New England journal of medicine 2003;349(4):335-42.
2003: Anthony V D'Amico; Judd W Moul; Peter R Carroll; Leon Sun; Deborah P Lubeck; Ming-Hui Chen
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2163-72.
2003: Anthony V D'Amico; Kerri Cote; Marian Loffredo; Andrew A Renshaw; Ming-Hui Chen
Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.
The Journal of urology 2003;169(4):1320-4.
2003: Andrew K Lee; Tatiana Doytchinova; Ming-Hui Chen; Andrew A Renshaw; Michael Weinstein; Jerome P Richie; Anthony V D'Amico
Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
Urologic oncology 2003;21(2):123-7.
2003: Anthony V D'Amico
Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapy.
Reviews in urology 2003;5 Suppl 6():S40-6.
2003: George C Cheng; Ming Hui Chen; Richard Whittington; S Bruce Malkowicz; Mitchell D Schnall; John E Tomaszewski; Anthony V D'Amico
Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA
International journal of radiation oncology, biology, physics 2003;55(1):64-70.

2003: Anthony V D'Amico; Kerri Cote; Marian Loffredo; Andrew A Renshaw; Ming-Hui Chen
Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma.
Cancer 2003;97(1):56-62.
2002: Anthony V D'Amico; George Toupless; Lynn Lopes; Kristin Valentine; Robert Cormack; Clare M C Tempany; Sanjaya Kumar; Peter J Marks
Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events.
International journal of radiation oncology, biology, physics 2002;54(5):1311-3.
2002: Anthony V D'Amico; Kerri Cote; Marian Loffredo; Andrew A Renshaw; Delray Schultz
Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4567-73.
2002: Anthony V D'Amico
How to compare results after surgery or radiation for localized prostate carcinoma.
Cancer 2002;95(10):2041-3.
2002: Prajnan Das; Ming-H Chen; Kristin Valentine; Lynn Lopes; Robert Cormack; Andrew A Renshaw; Clare M C Tempany; Sanjaya Kumar; Anthony V D'Amico
Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.
International journal of radiation oncology, biology, physics 2002;54(3):698-702.
2002: Anthony V D'Amico; Ming-Hui Chen; Jean Oh-Ung; Andrew A Renshaw; Kerri Cote; Marian Loffredo; Jerome P Richie
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era.
International journal of radiation oncology, biology, physics 2002;54(2):436-41.
2002: Jean O Ung; Jerome P Richie; Ming-Hui Chen; Andrew A Renshaw; Anthony V D'Amico
Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era.
Urology 2002;60(3):458-63.
2002: Jeong H Yoon; Ming-Hui Chen; Andrew A Renshaw; Jerome P Richie; Anthony V D'Amico
Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer.
Urology 2002;60(3):454-7.
2002: Anthony V D'Amico
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.
Urology 2002;60(3 Suppl 1):32-7; discussion 37-8.
2002: Masanori Hirose; Aditya Bharatha; Nobuhiko Hata; Kelly H Zou; Simon K Warfield; Robert Cormack; Anthony V D'Amico; Ron Kikinis; Ferenc A Jolesz; Clare M C Tempany
Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy.
Academic radiology 2002;9(8):906-12.
2002: Anthony V D'Amico
Predicting prostate-specific antigen recurrence established: now, who will survive?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3188-90.
2002: Mark Hurwitz; Lindsey Schnieder; Judith Manola; Clair Beard; Irving D Kaplan; Anthony V D'Amico
Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis.
International journal of radiation oncology, biology, physics 2002;53(5):1106-10.
2002: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
Cancer 2002;95(2):281-6.
2002: Anthony V D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A Renshaw; Daniel George; William Oh; Philip W Kantoff
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.
Cancer 2002;95(2):275-80.
2002: Marshal E Lieberfarb; Delray Schultz; Richard Whittington; Bruce Malkowicz; John E Tomaszewski; Michael Weinstein; Alan Wein; Jerome P Richie; Anthony V D'Amico
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy.
International journal of radiation oncology, biology, physics 2002;53(4):898-903.
2002: Anthony V D'Amico; Aparna Keshaviah; Judith Manola; Kerri Cote; Marian Loffredo; Olga Iskrzytzky; Andrew A Renshaw
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer.
International journal of radiation oncology, biology, physics 2002;53(3):581-7.
2002: Chaundre K Cross; Delray Shultz; S Bruce Malkowicz; William C Huang; Richard Whittington; John E Tomaszewski; Andrew A Renshaw; Jerome P Richie; Anthony V D'Amico
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2863-8.
2002: Patrick W Linson; Andrew K Lee; Tatiana Doytchinova; Ming-Hui Chen; Michael H Weinstein; Jerome P Richie; Anthony V D'Amico
Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
Urology 2002;59(5):704-8.
2002: Anthony V D'Amico; Ming-Hui Chen; S Bruce Malkowicz; Richard Whittington; Andrew A Renshaw; John E Tomaszewski; Yelina Samofalov; Alan Wein; Jerome P Richie
Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less.
The Journal of urology 2002;167(5):2025-30; discussion 2030-1.
2002: Dinesh Singh; Phillip G Febbo; Kenneth Ross; Donald G Jackson; Judith Manola; Christine Ladd; Pablo Tamayo; Andrew A Renshaw; Anthony V D'Amico; Jerome P Richie; Eric S Lander; Massimo Loda; Philip W Kantoff; Todd R Golub; William R Sellers
Gene expression correlates of clinical prostate cancer behavior.
Cancer cell 2002;1(2):203-9.
2001: Aditya Bharatha; M Hirose; Nobuhiko Hata; Simon K Warfield; Matthieu Ferrant; Kelly H Zou; E Suarez-Santana; Juan Ruiz-Alzola; Anthony V D'Amico; Robert Cormack; Ron Kikinis; Ferenc A Jolesz; Clare M C Tempany
Evaluation of three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging.
Medical physics 2001;28(12):2551-60.
2001: Anthony V D'Amico; Judith Manola; Marian Loffredo; Lynn Lopes; K Nissen; Desmond A O'Farrell; L Gordon; Clare M C Tempany; Robert Cormack
A practical method to achieve prostate gland immobilization and target verification for daily treatment.
International journal of radiation oncology, biology, physics 2001;51(5):1431-6.
2001: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; M Weinstein; John E Tomaszewski; Delray Schultz; M Rhude; S Rocha; Alan Wein; Jerome P Richie
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.
The Journal of urology 2001;166(6):2185-8.
2001: Anthony V D'Amico
Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer.
Cancer journal (Sudbury, Mass.) 2001;7(5):375-6.
2001: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Andrew A Renshaw; John E Tomaszewski; C Bentley; Delray Schultz; S Rocha; Alan Wein; Jerome P Richie
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening.
Urology 2001;58(3):406-10.
2001: R Cheung; Martin D Altschuler; Anthony V D'Amico; S Bruce Malkowicz; Alan J Wein; Richard Whittington
Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure.
Urology 2001;58(3):400-5.
2001: Anthony V D'Amico
Combined-modality staging for localized adenocarcinoma of the prostate.
Oncology (Williston Park, N.Y.) 2001;15(8):1049-59; discussion 1060-2, 1064-5, 1069-70,1073-5.
2001: Anthony V D'Amico
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.
Urology 2001;58(2 Suppl 1):78-82.
2001: Nobuhiko Hata; Masahiro Jinzaki; Daniel Kacher; R Cormak; DT Gering; Arya Nabavi; Stuart G Silverman; Anthony V D'Amico; Ron Kikinis; Ferenc A Jolesz; Clare M C Tempany
MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility.
Radiology 2001;220(1):263-8.
2001: Anthony V D'Amico; Robert Cormack; C M Tempany
MRI-guided diagnosis and treatment of prostate cancer.
The New England journal of medicine 2001;344(10):776-7.
2001: Anthony V D'Amico; Delray Schultz; Barbara Silver; L Henry; Mark Hurwitz; Irving Kaplan; Clair Beard; Andrew A Renshaw
The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2001;49(3):679-84.
2001: A K Lee; Delray Schultz; Andrew A Renshaw; Jerome P Richie; Anthony V D'Amico
Optimizing patient selection for prostate monotherapy.
International journal of radiation oncology, biology, physics 2001;49(3):673-7.
2001: R Cheung; Martin D Altschuler; Anthony V D'Amico; S Bruce Malkowicz; Alan J Wein; Richard Whittington
ROC optimization may improve risk stratification of prostate cancer patients.
Urology 2001;57(2):286-90.
2001: Anthony V D'Amico; Y Wu; Ming-Hui Chen; M Nash; Andrew A Renshaw; Jerome P Richie
Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
The Journal of urology 2001;165(1):126-9.
2000: Robert Cormack; Clare M C Tempany; Anthony V D'Amico
Optimizing target coverage by dosimetric feedback during prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;48(4):1245-9.
2000: Anthony V D'Amico; Y Wu; Ming-Hui Chen; M Nash; Andrew A Renshaw; Jerome P Richie
Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a gleason score
Cancer 2000;89(8):1810-7.

2000: Robert Cormack; Anthony V D'Amico; N Hata; S Silverman; M Weinstein; Clare M C Tempany
Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance.
Urology 2000;56(4):663-4.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Y H Wu; Ming-Hui Chen; Mark Hurwitz; Philip W Kantoff; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3240-6.
2000: Anthony V D'Amico; Delray Schultz; Marian Loffredo; R Dugal; Mark Hurwitz; Irving Kaplan; Clair Beard; Andrew A Renshaw; Philip W Kantoff
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 2000;284(10):1280-3.
2000: Anthony V D'Amico; Richard Whittington; B Malkowicz; Mitchell D Schnall; Delray Schultz; Kerri Cote; John E Tomaszewski; Alan Wein
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
The Journal of urology 2000;164(3 Pt 1):759-63.
2000: A F Olumi; Jerome P Richie; D J Schultz; Anthony V D'Amico
Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study.
Urology 2000;56(2):273-7.
2000: Anthony V D'Amico; Clare M C Tempany; Robert Cormack; N Hata; Masahiro Jinzaki; Kemal Tuncali; M Weinstein; Jerome P Richie
Transperineal magnetic resonance image guided prostate biopsy.
The Journal of urology 2000;164(2):385-7.
2000: M D Thomas; Robert Cormack; Clare M C Tempany; Sanjaya Kumar; Judith Manola; L Schneider; Mark Hurwitz; Anthony V D'Amico
Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;47(4):905-8.
2000: Anthony V D'Amico; D Schultz; L Schneider; Mark Hurwitz; Philip W Kantoff; J P Richie
Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors.
The Journal of urology 2000;163(6):1797-801.
2000: Mark Hurwitz; Robert Cormack; Clare M C Tempany; S Kumar; Anthony V D'Amico
Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer.
Techniques in urology 2000;6(2):89-94.
2000: Anthony V D'Amico; Robert Cormack; S Kumar; Clare M C Tempany
Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer.
Journal of endourology / Endourological Society 2000;14(4):367-70.
2000: Anthony V D'Amico; R Whittington; S B Malkowicz; Delray Schultz; J E Tomaszewski; A Wein
Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
Cancer 2000;88(9):2110-5.
2000: Anthony V D'Amico; M Weinstein; Xingde Li; Jerome P Richie; J Fujimoto
Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland.
Urology 2000;55(5):783-7.
2000: Anthony V D'Amico; R Whittington; S B Malkowicz; Y H Wu; M Chen; M Art; J E Tomaszewski; A Wein
Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer.
Urology 2000;55(4):572-7.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; J Fondurulia; M H Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1164-72.
2000: Hanne M Kooy; Robert Cormack; G Mathiowitz; Clare M C Tempany; Anthony V D'Amico
A software system for interventional magnetic resonance image-guided prostate brachytherapy.
Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2000;5(6):401-13.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Barbara Silver; L Henry; Mark Hurwitz; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
Molecular urology 2000;4(3):171-5;discussion 177.
2000: Robert Cormack; Hanne M Kooy; Clare M C Tempany; Anthony V D'Amico
A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging.
International journal of radiation oncology, biology, physics 2000;46(1):207-14.
1999: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Andrew A Renshaw; John E Tomaszewski; Jerome P Richie; Alan Wein
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.
International journal of radiation oncology, biology, physics 1999;45(5):1227-33.
1999: Anthony V D'Amico; A A Renshaw; D Schultz; S Rocha; J P Richie
The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c,2a: implications for patient selection for prostate-only therapy.
International journal of radiation oncology, biology, physics 1999;45(4):847-51.
1999: Anthony V D'Amico; A A Renshaw; L Arsenault; D Schultz; J P Richie
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy.
International journal of radiation oncology, biology, physics 1999;45(4):841-6.
1999: Anthony V D'Amico; N J Vogelzang
Prostate brachytherapy: increasing demand for the procedure despite the lack of standardized quality assurance and long term outcome data.
Cancer 1999;86(9):1632-4.
1999: Anthony V D'Amico; F Debruyne; H Huland; J P Richie
Innovative treatment for clinically localized adenocarcinoma of the prostate: the future role of molecular imaging.
The Prostate 1999;41(3):208-12.
1999: R G Prosnitz; L Schneider; Judith Manola; Sónia Rocha; Marian Loffredo; Lynn Lopes; Anthony V D'Amico
Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot study.
International journal of radiation oncology, biology, physics 1999;45(3):563-6.
1999: Sara O Vargas; MR Jiroutek; Anthony V D'Amico; Andrew A Renshaw
Distribution of carcinoma in radical prostatectomy specimens in the era of serum prostate-specific antigen testing. Implications for delivery of localized therapy.
American journal of clinical pathology 1999;112(3):373-6.
1999: Anthony V D'Amico
Analysis of the clinical utility of the use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy.
Urology 1999;54(2):201-3.
1999: Andrew A Renshaw; Jerome P Richie; Kevin R Loughlin; MR Jiroutek; A Chung; Anthony V D'Amico
Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients.
American journal of clinical pathology 1999;111(5):641-4.
1999: Anthony V D'Amico; A Davis; Sara O Vargas; Andrew A Renshaw; MR Jiroutek; Jerome P Richie
Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?
International journal of radiation oncology, biology, physics 1999;43(3):587-90.
1999: Sara O Vargas; MR Jiroutek; William R Welch; Marisa R Nucci; Anthony V D'Amico; Andrew A Renshaw
Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection.
American journal of clinical pathology 1999;111(2):223-8.
1999: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; J Fondurulia; M H Chen; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; Alan Wein; C Norman Coleman
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):168-72.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; J Fondurulia; M H Chen; John E Tomaszewski; Alan Wein
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.
The Journal of urology 1998;160(6 Pt 1):2096-101.
1998: Anthony V D'Amico; A Desjardin; Ming-Hui Chen; S Paik; Delray Schultz; Andrew A Renshaw; Kevin R Loughlin; Jerome P Richie
Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate.
Cancer 1998;83(10):2172-80.
1998: Anthony V D'Amico; Robert Cormack; Clare M C Tempany; Sanjaya Kumar; George P Topulos; Hanne M Kooy; C Norman Coleman
Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1998;42(3):507-15.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer.
Urology 1998;52(4):631-6.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; K Blank; G A Broderick; John E Tomaszewski; Andrew A Renshaw; Irving Kaplan; Clair Beard; Alan Wein
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 1998;280(11):969-74.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; K R Loughlin; Jerome P Richie; Alan Wein
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3094-100.
1998: Andrew A Renshaw; Jerome P Richie; Kevin R Loughlin; MR Jiroutek; A Chung; Anthony V D'Amico
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens.
Cancer 1998;83(4):748-52.
1998: Anthony V D'Amico; A Desjardin; A Chung; Ming-Hui Chen
Assessment of outcome prediction models for localized prostate cancer in patients managed with external beam radiation therapy.
Seminars in urologic oncology 1998;16(3):153-9.
1998: Anthony V D'Amico; A Desjardin; A Chung; Ming-Hui Chen; Delray Schultz; Richard Whittington; S Bruce Malkowicz; Alan Wein; John E Tomaszewski; Andrew A Renshaw; Kevin R Loughlin; Jerome P Richie
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy.
Cancer 1998;82(10):1887-96.
1998: Clair Beard; C Lamb; L Buswell; L Schneider; Kathleen J Propert; D Gladstone; Anthony V D'Amico; Irving Kaplan
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.
International journal of radiation oncology, biology, physics 1998;41(2):257-62.
1998: Anthony V D'Amico; Mitchell D Schnall; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease.
Urology 1998;51(3):449-54.
1998: Anthony V D'Amico; E Chang; Marc B Garnick; Philip W Kantoff; MR Jiroutek; Clare M C Tempany
Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy.
Urology 1998;51(2):287-92.
1998: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; Alan Wein; John E Tomaszewski; C Norman Coleman
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
Cancer 1998;82(2):334-41.
1997: Anthony V D'Amico; Richard Whittington; Delray Schultz; S Bruce Malkowicz; John E Tomaszewski; Alan Wein
Outcome based staging for clinically localized adenocarcinoma of the prostate.
The Journal of urology 1997;158(4):1422-6.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; John E Tomaszewski; Alan Wein; C Norman Coleman
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
International journal of radiation oncology, biology, physics 1997;39(2):335-40.
1997: Maria Werner-Wasik; Richard Whittington; S Bruce Malkowicz; BW Corn; Peter H Arger; S Reisinger; Curtis P Langlotz; A Alexander; Anthony V D'Amico; Terry Hyslop; L Gomella; K Brownstein; Alan J Wein
Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate.
Urology 1997;50(3):385-9.
1997: Andrew A Renshaw; H Chang; Anthony V D'Amico
Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice.
American journal of clinical pathology 1997;107(6):704-8.
1997: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1465-9.
1997: Anthony V D'Amico
Re: Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?
The Journal of urology 1997;157(4):1371; author reply 1372.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; MR Jiroutek; S Bruce Malkowicz; Alan Wein; C Norman Coleman
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
International journal of radiation oncology, biology, physics 1997;37(5):1053-8.
1997: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure.
Urology 1997;49(3A Suppl):23-30.
1997: Anthony V D'Amico; H Chang; Edward J Holupka; Andrew A Renshaw; A Desjarden; M Chen; Kevin R Loughlin; Jerome P Richie
Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage.
Urology 1997;49(3):385-91.
1997: Anthony V D'Amico; H Matelski; M O'Leary; B Sussman
Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer.
Urology 1997;49(2):279-82.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients.
The cancer journal from Scientific American 1996;2(6):343-50.
1996: Anthony V D'Amico
The role of MR imaging in the selection of therapy for prostate cancer.
Magnetic resonance imaging clinics of North America 1996;4(3):471-9.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1770-7.
1996: Anthony V D'Amico; Joel Goldwein; Richard B Womer
Alveolar rhabdomyosarcoma of the lip in an infant.
Medical and pediatric oncology 1996;26(6):409-13.
1996: Anthony V D'Amico; Kathleen J Propert
Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy.
International journal of radiation oncology, biology, physics 1996;35(2):273-9.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; K Loughlin; Delray Schultz; Mitchell D Schnall; Clare M C Tempany; John E Tomaszewski; Andrew A Renshaw; Alan Wein
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy.
Urology 1996;47(4):538-47.
1996: Anthony V D'Amico; I Kaplan
Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(1):73-6.
1996: Anthony V D'Amico; C Norman Coleman
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):304-15.
1995: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; D Schultz; Mitchell D Schnall; J E Tomaszewski; Alan J Wein
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
The Journal of urology 1995;154(1):131-8.
1995: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; D Schultz
A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1995;32(2):473-7.
1995: Anthony V D'Amico; Richard Whittington; Mitchell D Schnall; S Bruce Malkowicz; J E Tomaszewski; D Schultz; Alan J Wein
The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
Cancer 1995;75(9):2368-72.
1994: G D Kao; S B Malkowicz; R Whittington; Anthony V D'Amico; Alan J Wein
Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT.
Radiology 1994;193(3):725-30.
1994: Anthony V D'Amico; W Gillies McKenna
Apoptosis and a re-investigation of the biologic basis for cancer therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):3-10.
1994: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Mitchell D Schnall; J Tomaszewski; D Schultz; Gary D Kao; Keith VanArsdalen; Alan J Wein
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
International journal of radiation oncology, biology, physics 1994;30(2):293-302.
1993: Anthony V D'Amico; Gerald E Hanks
Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer.
Cancer 1993;72(9):2638-43.
1993: Anthony V D'Amico; Martin D Altschuler; R Whittington; G Kao; S Bruce Malkowicz; A Wein
The use of clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for prostate cancer.
Clinical performance and quality health care 1993;1(4):219-22.
1993: Gerald E Hanks; Anthony V D'Amico; B E Epstein; Timothy Schultheiss
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time.
International journal of radiation oncology, biology, physics 1993;27(1):125-7.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.